“…It is well known that anthraquinones can bind DNA by inserting and stacking between the base pairs of DNA double helices (Silverman, 2004). There are several proposed mechanisms regarding the drug's anticancer activity: one involves the drug's capability to intercalate DNA (Piedade et al, 2002;Hsiao et al, 2008) and to inhibit DNA topoisomerase II (Capranico et al, 1994;Perchellet et al, 2000;Teich et al, 2004;Dal Ben et al, 2007) and the other involves the drug's ability to produce free radicals and consequently to cleave DNA (Fisher et al, 1992;Tütem et al, 1996). In a recent study, we showed that derivatives of 2-(1-hydroxyalkyl)-1,4-dihydroxyl-9,10-anthraquinone displayed antitumor activity (Jin et al, 1998a(Jin et al, , 1998bTam et al, 2000).…”